University of Iowa Opioids Ideas Lab
- Discoverability
- Visible
- Join Policy
- Closed
- Created
- 27 Feb 2018
Addiction
| A | B | C | D | E | F | |
|---|---|---|---|---|---|---|
1 | OPPORTUNITY NUMBER | OPPORTUNITY TITLE | AGENCY CODE | AGENCY NAME | POSTED DATE | CLOSE DATE |
2 | PA-17-120 | Discovering Novel Targets: The Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01) | HHS-NIH11 | National Institutes of Health | 10/1/2017 | 7/1/2020 |
3 | PAR-18-231 | National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Addiction (U19 Clinical Trial Optional) | HHS-NIH11 | National Institutes of Health | 21/11/2017 | 24/2/2020 |
4 | PA-18-066 | International Research Collaboration on Drug Abuse and Addiction Research (R21 Clinical Trial Optional) | HHS-NIH11 | National Institutes of Health | 15/11/2017 | 7/5/2018 |
5 | PA-18-065 | International Research Collaboration on Drug Abuse and Addiction Research (R03 Clinical Trial Optional) | HHS-NIH11 | National Institutes of Health | 15/11/2017 | 7/5/2018 |
6 | PAR-18-084 | Integrative Research on Polysubstance Abuse and Addiction (R21/R33 Clinical Trial Optional) | HHS-NIH11 | National Institutes of Health | 17/11/2017 | 7/9/2019 |
7 | PA-18-568 | International Research Collaboration on Drug Abuse and Addiction Research (R01, Clinical Trial Optional) | HHS-NIH11 | National Institutes of Health | 9/1/2018 | 7/5/2018 |
8 | PA-18-057 | The Application of Big Data Analytics to Drug Abuse Research (R01 Clinical Trial Optional) | HHS-NIH11 | National Institutes of Health | 1/11/2017 | 7/5/2019 |
9 | PAR-18-230 | National Cooperative Drug/Device Discovery/Development Groups (U01 Clinical Trial Optional) | HHS-NIH11 | National Institutes of Health | 21/11/2017 | 24/2/2020 |
10 | PAR-18-086 | Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R21/R33 Clinical Trial Optional) | HHS-NIH11 | National Institutes of Health | 17/11/2017 | 7/9/2019 |
11 | PAR-18-085 | Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R33 Clinical Trial Optional) | HHS-NIH11 | National Institutes of Health | 17/11/2017 | 7/9/2019 |
12 | PA-17-119 | Basic Mechanisms of Brain Development Mediating Substance Use and Dependence (R01) | HHS-NIH11 | National Institutes of Health | 10/1/2017 | 7/1/2020 |
13 | PAR-17-458 | Population Assessment of Tobacco and Health (PATH) Biospecimen Access (X01) | HHS-NIH11 | National Institutes of Health | 15/8/2017 | 31/10/2020 |
14 | PA-18-073 | Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) | HHS-NIH11 | National Institutes of Health | 2/11/2017 | 7/1/2019 |
15 | PA-18-074 | Behavioral and Integrative Treatment Development Program (R03 Clinical Trial Optional) | HHS-NIH11 | National Institutes of Health | 2/11/2017 | 7/1/2019 |
16 | PA-18-055 | Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) | HHS-NIH11 | National Institutes of Health | 2/11/2017 | 7/1/2019 |
17 | PAR-18-064 | Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) | HHS-NIH11 | National Institutes of Health | 8/11/2017 | 8/11/2018 |
18 | PAR-18-083 | NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Optional) | HHS-NIH11 | National Institutes of Health | 17/11/2017 | 7/9/2018 |
19 | PAR-18-222 | Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) | HHS-NIH11 | National Institutes of Health | 30/11/2017 | 13/11/2020 |
20 | PAR-18-224 | NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) | HHS-NIH11 | National Institutes of Health | 30/11/2017 | 7/1/2019 |
21 | PAR-18-225 | NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) | HHS-NIH11 | National Institutes of Health | 30/11/2017 | 7/1/2020 |
22 | PAR-18-223 | Multi-Site Pilot and Feasibility Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional) | HHS-NIH11 | National Institutes of Health | 30/11/2017 | 13/11/2020 |
23 | PAR-18-437 | Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional) | HHS-NIH11 | National Institutes of Health | 9/1/2018 | 18/12/2020 |
24 | W81XWH18SBAA1 | DoD USAMRMC FY18-FY22 Broad Agency Announcement for Extramural Medical Research | DOD-AMRAA | Dept. of the Army -- USAMRAA | 1/10/2017 | 30/9/2022 |